According to figures cited by the Life Insurance Association Singapore (LIA) and drawn from WTW's 2026 Global Medical Trends report, Singapore's medical cost inflation is projected to reach a record 16.9% in 2026 — the highest in the Asia-Pacific region, and a sharp step up from around 12.3% in 2024 and 15.5% in 2025. LIA has publicly called for collective action from insurers, healthcare providers, consumers and regulators to contain the trend.
The article also links this to the new Integrated Shield Plan (IP) rider structure that took effect on 1 April 2026, in which the minimum deductible is no longer covered and the co-payment cap is doubled from S$3,000 to S$6,000 (please verify current figures with your insurer or MOH). New riders are, on average, meaningfully cheaper than the previous versions, but LIA has been careful to note that lower premium does not automatically mean better value — coverage differs, and expectations set today can create shortfalls later.
At StickieMonies, we take the 16.9% number as a planning signal, not a headline. Even if actual inflation lands lower, three things are worth internalising. First, healthcare premiums typically rise with age on top of medical inflation, so a policy that is comfortable at 40 may feel very different at 65. Second, the newer rider designs shift more of a bad-year hospital bill onto the patient — meaning your emergency cash buffer needs to sit alongside your insurance, not behind it. Third, private-hospital access and cancer drug cover are not free extras; they are choices with a cost.
The practical work we do with clients in this environment usually looks like this: review current IP and rider terms against likely healthcare use over the next decade; stress-test the household's ability to absorb the new co-payment cap in a serious hospitalisation year; check whether MediSave balances and hospitalisation cash cover are aligned with the plan; and, where relevant, consider whether critical illness or disability cover is appropriately sized so that a bad diagnosis does not force a rushed downgrade of the IP later.
None of the above is a recommendation to buy or drop any specific IP, rider or insurer. Every household's answer is different, and premiums, benefits and non-guaranteed features change over time. Insurance and investment decisions carry risk — including changing premiums, changing benefits, and the possibility that a chosen structure no longer suits your circumstances in future — and are worth discussing with a qualified financial adviser.
If you'd like a second pair of eyes on your existing health coverage in light of this year's projections, we're glad to walk through it with you. The original Business Times report is linked below.